Cypress Capital Management (Wyoming)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-100
Closed -$1K 337
2017
Q3
$1K Hold
100
﹤0.01% 263
2017
Q2
$1.7K Buy
+100
New +$1.7K ﹤0.01% 254